Scientific Excellence. Global Perspectives. One Elixiron.
At Elixiron, we believe that meaningful innovation begins with rigorous science, medical expertise, and the collective dedication of a passionate team.
On October 22, 2026, we hosted our Scientific Advisory Board (SAB) Meeting & Science Day, bringing together distinguished international scientists, medical experts, and the Elixiron team for inspiring scientific exchanges and strategic discussions.
During the SAB Meeting, we reviewed the progress and development strategies of our key programs, Indemakitug (EI-001) and Enrupatinib (EI-1071), benefiting from the valuable insights and guidance of our scientific advisors.
Science Day further broadened the scientific dialogue, exploring advances in immunology, rare diseases, neuroinflammation, and neurodegenerative disorders, reinforcing our commitment to science-driven innovation and addressing unmet medical needs.
We extend our sincere gratitude to our Scientific Advisory Board members, including Dr. Boris Skurkovich, Dr. Christina de Min, Dr. Fabrizio de Benedetti, Prof. Francisco Javier Quintana, Prof. Hugo J. Bellen, Prof. Jean-Laurent Casanova, and Prof. Li-Fan Lu for for sharing their scientific expertise and valuable perspectives. Their insights contribute to our scientific discussions and help inform our ongoing research and development efforts.
Beyond scientific discussions, the event also celebrated the passion, dedication, and collaborative spirit of the entire Elixiron team. Every step forward reflects the contributions of colleagues across functions, united by a shared mission.
With a strong scientific foundation, global perspectives, and a united team, Elixiron remains committed to advancing innovative therapeutics and making a meaningful difference in patients' lives worldwide.
Grounded in science. United in purpose. Advancing innovation for patients.
